Cracking the code of advanced prostate cancer

Figure: age-adjusted cancer death rates per 100,000 U.S. men, by tumor site (American Cancer Society)For men in the U.S., prostate cancer is the second-leading cause of cancer death. Not all prostate...

A new line of attack on deadly prostate cancers

Researchers have uncovered a potential drug target for stopping castration-resistant prostate tumors – the second leading cause of cancer death in the U.S. For decades, drug development for...

Exercise as medicine for cancer: Q&A with Kerri Winters-Stone

Cancer patients don’t need to avoid physical exertion, including exercise – contrary to once widely held belief. Exercise is not only safe during and after cancer treatment, studies have found...

Making sense of colorectal cancer screening choices

Colorectal cancer is the third most common cause of cancer death among men and women in the U.S. But there is shockingly large regional variation in mortality, in part because of sharp differences...

Taking stock of the evidence for ‘off-label’ use of cancer drugs

Doctors often expand the use of cancer drugs to situations beyond those explicitly approved by the Food and Drug Administration. And health plans will pay for those uses as long as they are supported...

What magnitude of benefit is meaningful to cancer patients?

Oncologists often use the phrase "clinically meaningful benefit" to describe the effect of an experimental treatment. But is the benefit meaningful for patients? A new paper suggests that benefit...

Cancer translated’s top blog posts of 2017

From basic science to survivorship and patient advocacy, the OHSU Knight Cancer Institute’s 'Cancer translated' blog explores new ideas and debates in cancer medicine. We sorted a year’s worth...